Key result
STAT1 knockout preserves diastolic function and increases reparative cardiac myeloid cells after renal ischemia-reperfusion.
Why the study?
The STAT1 pathway coordinates immune-metabolic communication and is downregulated in the myocardium during chronic kidney disease, prompting this investigation into how STAT1 signaling affects structural, functional, and immunological cardiac remodeling in CKD-induced cardiac dysfunction.
Does STAT1 knockout prevent CKD-induced diastolic dysfunction and alter cardiac myeloid immune responses in mice subjected to unilateral renal ischemia-reperfusion injury?
Does STAT1 knockout prevent CKD-induced diastolic dysfunction and alter cardiac myeloid immune responses in mice subjected to unilateral renal ischemia-reperfusion injury?
In a preclinical mouse model of chronic kidney injury, STAT1 deficiency protects against diastolic dysfunction and promotes reparative cardiac myeloid cell expansion, particularly in males, highlighting a sex-dependent immune mechanism along the kidney-heart axis.
Answers are grounded in this paper and cite their sources.
Should not change clinical practice in cardiorenal disease; leaves open STAT1 as a mechanistic target for future studies.
Background Signal Transducer and Activator of Transcription-1 (STAT1) pathway serves as a central hub coordinating immune-metabolic communication and cardiac remodeling. We reanalyzed publicly available human myocardial proteomic data from a recent study by Jani et al.(1) which showed significant downregulation of STAT1 in proteomic analysis of human myocardium from diabetic kidney disease patients versus healthy controls which was consistent with our findings in a swine chronic kidney disease (CKD) model with similarly reduced cardiac STAT1 expression (Fig. 1A,B). Objectives To investigate the impact on structural, functional, and immunological cardiac remodeling of STAT1 signaling CKD induced cardiac dysfunction. Methods Chronic kidney disease (CKD) was induced by 30 minutes of unilateral ischemia reperfusion (IRI) of the left kidney in 8 week-old transgenic STAT1 knockout (STAT1−/−) and wild-type (WT) mice. Echocardiography was performed to assess parameters such as E/A ratio. Bulk RNA sequencing was performed on left ventricular (LV) myocardium and flow cytometry was conducted on whole blood and LV tissue to quantify immune cells. All analyses were performed with sex-stratified evaluation to identify potential sex-specific effects Results Bulk RNA sequencing of LV at 30 days after renal IRI revealed alterations in the JAK–STAT pathway in WT mice versus sham (Fig. 1C), highlighting a critical role of STAT1 in post-injury cardiac remodeling. Renal IRI induced atrophy of the left kidney and an initial reduction in heart weight that partially recovered by 90 days (Fig. 2A–C). Echocardiography showed that kidney injury led to a reduced E/A ratio in WT mice at 30 days (Fig. 2B), an effect absent in Stat1⁻/⁻ mice (Fig. 2D,E).Systemic immune profiling revealed elevated circulating Ly6C^int monocytes and reduced neutrophils in Stat1⁻/⁻ mice versus WT sham (Fig. 2F,G), with Ly6C^int monocytes remaining higher at 30 days in Stat1⁻/⁻ than in WT. Cardiac FACS at 90 days post-IRI showed pronounced immune cell expansion in Stat1⁻/⁻ hearts; macrophages (CD11b⁺F4/80⁺), tissue-resident macrophages (F4/80⁺CD64⁺), and patrolling Ly6C⁻ monocytes were significantly elevated in Stat1⁻/⁻ versus sham (Fig. 2H–L). These changes were predominantly observed in males, whereas females showed attenuated responses, underscoring sex-dependent immune and remodeling outcomes. Conclusions STAT1-dependent immune dysregulation after renal IRI shapes remote cardiac remodeling. Elevated circulating Ly6C^int monocytes and reduced neutrophils at baseline in Stat1⁻/⁻ mice are associated with a later expansion of reparative cardiac myeloid subsets at 90 days and preserved diastolic function. In contrast, WT mice develop more pronounced diastolic dysfunction despite comparable renal atrophy, particularly in males, indicating that STAT1-modulated systemic immune priming drives divergent cardiac outcomes along the kidney–heart axis.
No takes yet. Share an insight, caveat, or question.
Sen et al. (2026) studied Chronic kidney disease-induced cardiac dysfunction. STAT1 knockout (STAT1-/-) vs. Wild-type (WT) and sham mice was evaluated on Structural, functional (echocardiographic E/A ratio), and immunological cardiac remodeling. STAT1 knockout preserved the echocardiographic E/A ratio at 30 days and increased reparative cardiac myeloid subsets at 90 days post-renal ischemia-reperfusion compared with wild-type mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: